February 12, 2019
Sumitomo Dainippon Pharma and Aikomi, a digital health technology startup, entered into a joint research agreement for medical devices to relieve behavioral and psychological symptoms of dementia (BPSD), they said on February 8. Under the terms of the deal, they...read more